[Histonet] RE: breast fixation times

Thu Oct 28 16:50:11 CDT 2010

Great discussion, comprehensive yet concise.  Thanks Bill and Joyce and
Melissa. 

Steve

-----Original Message-----
From: histonet-bounces <@t> lists.utsouthwestern.edu
[mailto:histonet-bounces <@t> lists.utsouthwestern.edu] On Behalf Of Tench,
Bill
Sent: Wednesday, October 27, 2010 12:26 PM
To: Weems, Joyce; histonet <@t> lists.utsouthwestern.edu
Subject: [Histonet] RE: breast fixation times

My apologies for not including the updates accurate for ER and PR. 

Bill Tench
Associate Dir. Laboratory Services
Chief, Cytology Services
Palomar Medical Center
555 E. Valley Parkway
Escondido, California  92025
Bill.Tench <@t> pph.org
Voice: 760- 739-3037
Fax: 760-739-2604

-----Original Message-----
From: Weems, Joyce [mailto:JWeems <@t> sjha.org]
Sent: Wednesday, October 27, 2010 9:22 AM
To: Tench, Bill; histonet <@t> lists.utsouthwestern.edu
Subject: RE: breast fixation times

Thanks for this good explanation, Bill.

One can not follow the guidelines and document the variant in the
report, but not following them could hurt the patient if there is a
clinical trial they might participate in. Clinical trials follow the
protocol to the letter and if the FDA requirement is not met, the
patient can not participate. 

The times were extended for ER and PR to 72 hours, but NOT yet for Her2.
So...because the tissue is all the same, we must follow the 48 hour
limit. We just had a case this weekend. Had the clinical staff remove it
from the processor on Sun morning and embedded it Monday. We don't
ususally have this problem as we are a 6-day lab, but it was finished
too late on Fri. 

Cheers,j

Joyce Weems
Pathology Manager
Saint Joseph's Hospital
5665 Peachtree Dunwoody Rd NE
Atlanta, GA 30342
678-843-7376 - Phone
678-843-7831 - Fax 

-----Original Message-----
From: histonet-bounces <@t> lists.utsouthwestern.edu
[mailto:histonet-bounces <@t> lists.utsouthwestern.edu] On Behalf Of Tench,
Bill
Sent: Wednesday, October 27, 2010 11:50
To: histonet <@t> lists.utsouthwestern.edu
Subject: [Histonet] breast fixation times

There is no exception for core biopsies, as reasonable as that may seem.
I have had that discussion with the purveyors of the guidelines.  6-48
is the current standard.  there was a lot of discussion about exceeding
48 and using the FISH option.  My colleague responsible for this wrote:
It is in the CAP checklist, ANP 22998:

If the laboratory assesses Her2 by IHC or Her2 gene amplification by
in-situ hybridization (FISH, CISH, SISH), does the lab have a documented
procedure for ensuring appropriate length of fixation of specimens
tested? 

Specimens subject to Her2 testing should be fixed in 10% neutral
buffered formalin for at least 6 hours and no longer than 48 hours.
While fixation outside of these time limits is not an absolute exclusion
criterion for Her2 testing, labs should qualify any negative results for
specimens fixed less than 6 hours or longer than 48 hours. For cases
with negative results by IHC, consideration should be given to
performing confirmatory analysis by in-situ hybridization. 

 There is also a table in the original ASCO/CAP Guideline
Recommendations for Her2 in Breast Cancer (Arch Pathol Lab Med, Vol 131,
Jan 2007) that states that tissue fixed in formalin for greater than 48
hours is not an absolute exclusion criterion, but if known to be fixed
longer than 48 hours or unknown, the report should qualify any negative
result with this information (table 6). 

As for upcoming changes, i don't know other than these time limitations
are suppose to be more rigorously applied to ER and PR, along with the
newly instituted documentation of time between excision and time placed
in fixative.

Bill Tench
Associate Dir. Laboratory Services
Chief, Cytology Services
Palomar Medical Center
555 E. Valley Parkway
Escondido, California  92025
Bill.Tench <@t> pph.org
Voice: 760- 739-3037
Fax: 760-739-2604

[None] made the following annotations
---------------------------------------------------------------------
Confidential E-Mail: This e-mail is intended only for the person or
entity to which it is addressed, and may contain information that is
privileged, confidential, or otherwise protected from disclosure.
Dissemination, distribution, or copying of this e-mail or the
information herein by anyone other than the intended recipient is
prohibited. If you have received this e-mail in error, please notify the
sender by reply e-mail, and destroy the original message and all copies.

---------------------------------------------------------------------

_______________________________________________
Histonet mailing list
Histonet <@t> lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet
Confidentiality Notice:
This e-mail, including any attachments is the property of Catholic
Health East and is intended for the sole use of the intended
recipient(s).  
It may contain information that is privileged and confidential.  Any
unauthorized review, use, disclosure, or distribution is prohibited. If
you are not the intended recipient, please delete this message, and
reply to the sender regarding the error in a separate email. 

[None] made the following annotations
---------------------------------------------------------------------
Confidential E-Mail: This e-mail is intended only for the person or
entity to which it is addressed, and may contain information that is
privileged, confidential, or otherwise protected from disclosure.
Dissemination, distribution, or copying of this e-mail or the
information herein by anyone other than the intended recipient is
prohibited. If you have received this e-mail in error, please notify the
sender by reply e-mail, and destroy the original message and all copies.

---------------------------------------------------------------------

_______________________________________________
Histonet mailing list
Histonet <@t> lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet